(telephonic replay through November 16, 2021)
- (telephonic replay through November 16, 2021)
Harrow Health, Inc. (NASDAQ: HROW) is an ophthalmic-focused healthcare company.
- The Company owns and operates ImprimisRx , one of the nations leading ophthalmology-focused pharmaceutical businesses, and Visionology , a direct-to-consumer eye care subsidiary focused on chronic vision care.
- Harrow Health also holds non-controlling equity positions in Eton Pharmaceuticals , Surface Ophthalmics and Melt Pharmaceuticals , all of which started as Harrow Health subsidiaries, and owns royalty rights in four clinicalstage drug candidates being developed by Surface Ophthalmics and Melt Pharmaceuticals.
- For more information about Harrow Health, please visit the Investors section of the corporate website, harrowinc.com .